The market orientation has been found to be a major driver of innovation performance in service contexts. This issue raises questions concerning the extent to which the relationship market orientation-innovation performance link holds in the high-tech industry. Relatively litter research has examined how market orientation contributes to innovation performance through service innovation. We rep...

Regardless of where health reform efforts lead, the major stakeholders of the U.S. health system – patients, providers, payers, employers, communities, and government – will continue to demand greater value. The value concept relates to the quality of benefits and outcomes received for the price that is paid. Essentially, better value emerges with improvements in quality, delivery, access, and ...

• Set against the baseline perspective that health care organizations are complex adaptive systems whose future states are unpredictable and unknowable, the purpose of this chapter is to introduce a perspective of health care organizations that borrows from quantum theory and chaos theory to describe innovation and change not as rational, controllable processes, but instead as complex, uncertai...

Commercial insurance companies' have the market incentives and the ability to take on a new role as controllers of rising health care costs. This Note will discuss the market for insurer-directed cost containment, the types of cost control alternatives that could be utilized and the legal restraints on insurer innovation. The analysis of the legal setting for insurer innovation in cost control ...

In 2008, the Global strategy and plan of action on public health, innovation and intellectual property (GSPA-PHI) was launched by the World Health Organization, to stimulate fresh thinking on innovation in, and access to, medicines and to build sustainable research on diseases disproportionately affecting low- and middle-income countries. As part of the activities of the GSPA-PHI, Sri Lanka has...

R&D has always been considered a strategic asset of companies. Traditionally, companies that have their own R&D function are better prepared to compete in the globalized economy because they are able to produce the knowledge and technology required to advance products and services. SMEs also need to become highly innovative and competitive in order to be successful. Nevertheless, their ability ...

The Global Health 2035 report notes that the "grand convergence"--closure of the infectious, maternal, and child mortality gap between rich and poor countries--is dependent on research and development (R&D) of new drugs, vaccines, diagnostics, and other health tools. However, this convergence (and the R&D underpinning it) will first require an even more fundamental convergence of the different ...

The National Health Service (NHS) is the largest employer in the UK and since the late 1990s has gone through a period of unprecedented change in a wide range of areas from introduction of the NHS plan (Department of Health, 2000) designed to help the NHS meet the needs of patients and improve health outcomes; to the establishment of NHS Foundation Trusts in 2004 which have financial freedoms a...